Puerarin protects against β-amyloid-induced microglia apoptosis via a PI3K-dependent signaling pathway

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Radix puerariae contains puerarin, known for antioxidant and neuroprotective properties.
• Amyloid-beta protein (Aβ) is implicated in Alzheimer's disease pathogenesis, causing cytotoxicity.
• Microglial cells play a crucial role in neuroinflammation and response to Aβ.

Purpose of the Study:

• To investigate the protective effects of puerarin against Aβ-induced cytotoxicity in microglial cells.
• To elucidate the underlying mechanisms of puerarin's neuroprotection.
• To assess puerarin's potential as a therapeutic agent for Alzheimer's disease.

Main Methods:

• BV-2 and primary microglial cells were treated with puerarin before exposure to Aβ.
• Apoptosis was assessed using assays like activated caspase-3.
• Expression of apoptosis-related proteins (Bcl-2, Bax), Akt phosphorylation, and cytochrome c release were analyzed.
• Mitochondrial membrane potential and reactive oxygen species (ROS) production were measured.
• The role of the PI3K/Akt pathway was investigated using the inhibitor LY294002.

Main Results:

• Puerarin pretreatment protected BV-2 and primary microglial cells from Aβ-induced cytotoxicity by inhibiting apoptosis.
• Puerarin increased phospho-Akt and Bcl-2 expression while decreasing Bax expression and cytochrome c release.
• Puerarin prevented mitochondrial membrane potential loss and reduced ROS production.
• The protective effects of puerarin were abolished by LY294002, indicating PI3K/Akt pathway involvement.

Conclusions:

• Puerarin exerts neuroprotective effects against Aβ-induced microglial apoptosis.
• The mechanism involves the activation of the PI3K/Akt signaling pathway.
• Puerarin shows promise as a potential preventive or therapeutic agent for Alzheimer's disease.